Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholder Letter

Re: Shareholder Letter

posted on Feb 10, 2008 08:52AM

I wish David Pohl good luck in his retirement and anxiously await the announcement of his replacement.

Me also... and I want to state Mr Pohl's replacement as Chair had better not be Carlton Johnson...

jmo

Share
New Message
Please login to post a reply